A detailed history of Wood Trust Financial Corp transactions in Dexcom Inc stock. As of the latest transaction made, Wood Trust Financial Corp holds 12,562 shares of DXCM stock, worth $803,968. This represents 0.28% of its overall portfolio holdings.

Number of Shares
12,562
Previous 12,560 0.02%
Holding current value
$803,968
Previous $1.56 Million 11.87%
% of portfolio
0.28%
Previous 0.27%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

BUY
$114.22 - $140.1 $228 - $280
2 Added 0.02%
12,562 $1.74 Million
Q4 2023

Jan 23, 2024

BUY
$75.49 - $124.16 $45,294 - $74,496
600 Added 5.02%
12,560 $1.56 Million
Q3 2023

Oct 16, 2023

SELL
$86.06 - $137.93 $12,909 - $20,689
-150 Reduced 1.24%
11,960 $1.12 Million
Q4 2022

Jan 23, 2023

SELL
$84.98 - $122.67 $127,470 - $184,005
-1,500 Reduced 11.02%
12,110 $1.37 Million
Q3 2022

Oct 28, 2022

BUY
$76.35 - $94.18 $484,364 - $597,477
6,344 Added 87.31%
13,610 $1.1 Million
Q2 2022

Jul 22, 2022

BUY
$67.99 - $132.89 $305,071 - $596,277
4,487 Added 161.46%
7,266 $541,000
Q1 2022

Apr 25, 2022

BUY
$94.08 - $130.2 $59,270 - $82,026
630 Added 29.32%
2,779 $1.42 Million
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $19,480 - $24,423
150 Added 7.5%
2,149 $1.15 Million
Q3 2021

Nov 08, 2021

BUY
$106.71 - $143.18 $111,511 - $149,623
1,045 Added 109.54%
1,999 $1.09 Million
Q2 2021

Aug 03, 2021

BUY
$80.99 - $107.93 $22,677 - $30,220
280 Added 41.54%
954 $407,000
Q1 2021

Apr 22, 2021

SELL
$84.79 - $104.74 $10,598 - $13,092
-125 Reduced 15.64%
674 $242,000
Q4 2020

Jan 21, 2021

SELL
$78.0 - $104.5 $3,588 - $4,807
-46 Reduced 5.44%
799 $295,000
Q2 2020

Jul 29, 2020

BUY
$62.68 - $105.34 $52,964 - $89,012
845 New
845 $343,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $24.7B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Wood Trust Financial Corp Portfolio

Follow Wood Trust Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wood Trust Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Wood Trust Financial Corp with notifications on news.